كندا - الإنجليزية - Health Canada

sivem pharmaceuticals ulc - pantoprazole (pantoprazole sodium sesquihydrate) - tablet (delayed-release) - 20mg - pantoprazole (pantoprazole sodium sesquihydrate) 20mg - proton-pump inhibitors

كندا - الإنجليزية - Health Canada

sivem pharmaceuticals ulc - pantoprazole (pantoprazole sodium sesquihydrate) - tablet (delayed-release) - 40mg - pantoprazole (pantoprazole sodium sesquihydrate) 40mg - proton-pump inhibitors

كندا - الإنجليزية - Health Canada

laboratoire riva inc. - pantoprazole (pantoprazole sodium sesquihydrate) - tablet (delayed-release) - 20mg - pantoprazole (pantoprazole sodium sesquihydrate) 20mg - proton-pump inhibitors

كندا - الإنجليزية - Health Canada

laboratoire riva inc. - pantoprazole (pantoprazole sodium sesquihydrate) - tablet (delayed-release) - 40mg - pantoprazole (pantoprazole sodium sesquihydrate) 40mg - proton-pump inhibitors

كندا - الإنجليزية - Health Canada

teva canada limited - pantoprazole (pantoprazole magnesium) - tablet (delayed-release) - 40mg - pantoprazole (pantoprazole magnesium) 40mg - proton-pump inhibitors

كندا - الإنجليزية - Health Canada

altius healthcare inc - pantoprazole (pantoprazole magnesium) - tablet (enteric-coated) - 40mg - pantoprazole (pantoprazole magnesium) 40mg - proton-pump inhibitors

كندا - الإنجليزية - Health Canada

biomed pharma - pantoprazole (pantoprazole sodium sesquihydrate) - tablet (delayed-release) - 40mg - pantoprazole (pantoprazole sodium sesquihydrate) 40mg - proton-pump inhibitors

كندا - الإنجليزية - Health Canada

sanis health inc - pantoprazole (pantoprazole magnesium hemipentahydrate) - tablet (delayed-release) - 40mg - pantoprazole (pantoprazole magnesium hemipentahydrate) 40mg - proton-pump inhibitors

كندا - الإنجليزية - Health Canada

mantra pharma inc - pantoprazole (pantoprazole sodium sesquihydrate) - tablet (delayed-release) - 40mg - pantoprazole (pantoprazole sodium sesquihydrate) 40mg - proton-pump inhibitors

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

btg international inc. - crotalus atrox immune fab antivenin (ovine) (unii: rbr61yaj4v) (crotalus atrox immune fab antivenin (ovine) - unii:rbr61yaj4v), agkistrodon piscivorus immune fab antivenin (ovine) (unii: ia6o0k772m) (agkistrodon piscivorus immune fab antivenin (ovine) - unii:ia6o0k772m), crotalus scutulatus immune fab antivenin (ovine) (unii: 7wz1744g86) (crotalus scutulatus immune fab antivenin (ovine) - unii:7wz1744g86), crotalus adamanteus immune fab antivenin (ovine) (unii: a4229a7019) (crotalus adamanteus immune fa - crotalus atrox immune fab antivenin (ovine) 1 g - crofab is indicated for the management of adult and pediatric patients with north american crotalid envenomation. the term crotalid is used to describe the crotalinae subfamily (formerly known as crotalidae) of venomous snakes which includes rattlesnakes, copperheads and cottonmouths/water moccasins. do not administer crofab to patients with a known history of hypersensitivity to papaya or papain unless the benefits outweigh the risks and appropriate management for anaphylactic reactions is readily available. risk summary animal reproduction studies have not been conducted with crofab. it is also not known whether crofab can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. crofab should be given to a pregnant woman only if clearly needed. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. risk summary it is not known whether crofab is excret